JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Electric lighting & wiring equipment
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Energy Focus, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of Histogen Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Services-employment agencies
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of ShiftPixy, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Deep sea foreign transportation of freight
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.004 per share, of Globus Maritime Limited. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Services-computer programming services
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001, of Inpixon. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Scopus BioPharma Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Clarus Therapeutics Holdings, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Catalyst Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Surgical & medical instruments & apparatus
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, no par value per share, of Dynatronics Corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Services-business services, nec
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001, of Protagenic Therapeutics, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value per share, of Vanda Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
AGREEMENTAmendment No. 2 to Schedule 13g • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Spectrum Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Ordinary Shares, par value NIS 0.25, of ReWalk Robotics Ltd. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.01, of Deciphera Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 14th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Enanta Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • June 21st, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value per share, of Tenax Therapeutics, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Retail-eating & drinking places
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Muscle Maker, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Services-business services, nec
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of OLB Group, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of Trevi Therapeutics, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Travere Therapeutics, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Madrigal Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001 per share, of CytRx Corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Surgical & medical instruments & apparatus
The undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of ReShape Lifesciences Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the American Depositary Shares, each representing six ordinary shares, CHF 1.00 per share, nominal value CHF 1.00 per share, of Addex Therapeutics Ltd. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Services-misc health & allied services, nec
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01, of Baudax Bio, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.00001 per share, of Conformis, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Ordinary Shares, nominal value €0.10 per share, of ERYTECH Pharma S.A. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Citius Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Real estate investment trusts
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Series A Common Stock, $0.01 par value per share, of Presidio Property Trust, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • In vitro & in vivo diagnostic substances
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Lantheus Holdings, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Enanta Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Exicure, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Bellicum Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Armistice Capital, LLC • Finance services
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Ordinary Shares, par value $0.01 per share, of Bit Digital, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
